Pinzon RT, Wijaya VO, Veronica V
Nissen observes, because studies of these drugs for obesity show that they reduce death due to various other causes. After median treatment of 47.4 months, the six-component cardiorenal end point occurred in 23.7% of tirzepatide-treated patients versus 27.4% of dulaglutide-treated patients, translating to a hazard ratio (HR) of 0.84 (95% CI, 0.79-0.90
Injectable semaglutide (Ozempic, Wegovy) does not have specific meal timing requirements
Last updated June 3, 2026 Editorial policy The Dual Effect No One Expected When patients started reporting that their GLP-1 medications were curbing both their appetite and their desire to drink, clinicians paid attention
Since dietary intake may not always be sufficient, many people choose a high-quality l carnitine supplement to support performance and recovery
Semaglutide can be a valuable tool in controlling diabetes, but it is not a treatment for glaucoma